The FDA wrapped up 2024 with 50 new drug approvals, clearing a wave of long-awaited treatments. Meanwhile, Transcarent will ...

The FDA’s breakthrough therapy designation for GSK’227 underscores its potential to address the critical unmet needs of ...

"FDA awards GSK breakthrough status for relapsed osteosarcoma treatment" was originally created and published by ...

The nominations of Robert F. Kennedy Jr., noted corn syrup critic, as the Secretary of Health and Human Services and Brooke ...

The Food and Drug Administration put guidelines in place to curb the amount of lead in baby food, but some like one Illinois congressman say more should be done.

Speaking with Stat ahead of his exit, Robert Califf expressed concern about the potential for brain drain in government. Other news is on promising drugs for lung cancer patients, the upcoming J.P.

A Biologics License Application has been submitted to the FDA for treatment with the kidney cancer imaging PET drug product, Zircaix®.

Pro-cannabis businesses have accused the U.S. Drug Enforcement Administration of "an unalterably closed mind" toward lowering marijuana to a less-dangerous category level and said the federal agency ...

The New Brunswick, N.J., pharmaceutical giant said posdinemab has shown potential in targeting disease-associated phosphorylated tau in cerebrospinal fluid from treated Alzheimer's patients, and in ...

H1 named Dr. Stephen Hahn, former commissioner of the Food and Drug Administration, to its board of directors.

Abortions done via medication, also called chemical abortions, currently account for about half of the abortions that are ...

The FDA has set maximum levels for lead in baby food. A new California law requires baby food makers selling products in the ...